Skip to main content

Table 1 Results of the cost-utility analysis of different strategies of HD and PD

From: Peritoneal dialysis vs. hemodialysis among patients with end-stage renal disease in Iran: which is more cost-effective?

Scenario

Costs (million IRR)

QALY

Incremental costs

Incremental QALY

ICER

S1 (base case)

4750.5

2.6756

-

-

-

S2

4846.8

2.7181

96.4

0.0425

2268.2

S3

4918.2

2.7496

71.4

0.0315

2266.7

S4

4989.6

2.7811

71.4

0.0315

2266.7